Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasui, K.
Right arrow Articles by Suzuki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasui, K.
Right arrow Articles by Suzuki, H.
(Journal of Leukocyte Biology. 2002;72:1020-1026.)
© 2002 by Society for Leukocyte Biology

Granulocyte macrophage-colony stimulating factor delays neutrophil apoptosis and primes its function through Ia-type phosphoinositide 3-kinase

Kozo Yasui*, Yukio Sekiguchi*, Motoki Ichikawa*, Haruo Nagumo*, Takashi Yamazaki*, Atsushi Komiyama* and Harumi Suzuki{dagger}

* Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; and
{dagger} Department of Microbiology and Immunology, Yamaguchi University School of Medicine, Japan

Correspondence: Kozo Yasui, M.D., Ph.D., Department of Pediatrics, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan. E-mail: k-yasui{at}hsp.md.shinshu-u.ac.jp


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Phosphoinositide 3-kinases (PI3Ks) constitute a family of lipid kinases that regulate an array of fundamental cellular responses by neutrophils [polymorphonuclear leukocytes (PMN)]. p85{alpha} Gene-disrupted mice were used to help accurately identify the physiological role of the PI3K isoform in PMN activation in the presence of granulocyte macrophage-colony stimulating factor (GM-CSF). PMN from the p85{alpha}-/- mice showed normal cellular motility, and the quantity of superoxide anion (O2-) produced by PMN upon stimulation with formyl-Met-Leu-Phe did not significantly differ between p85{alpha}-/- and wild-type mice under controlled conditions. In p85{alpha}-/- mice, the O2- production by PMN was enhanced (primed) by GM-CSF when stimulated with the chemotactic peptide but to a significantly lesser extent than in wild-type mice. In addition, no major GM-CSF-dependent delay in apoptosis or activation of Akt protein phosphorylation by GM-CSF was observed in the p85{alpha}-/- mice. In terms of targeting strategy, however, the mutation actually expressed a small amount of Ia-type (p85{alpha}-regulated) PI3K activity (partially abrogated) in the mice. These results demonstrate that Ia-type PI3K plays a critical role in the enhancement of the GM-CSF-modulated function of PMN and in the PI3K/Akt pathway-dependent delay of PMN apoptosis.

Key Words: rodent • knockout • signal transduction • cytokines


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Granulocyte macrophage-colony stimulating factor (GM-CSF) is a glycoprotein of 22 kDa released by several activated cell types that promotes the growth and differentiation of myelomonocytic progenitors [1 , 2 ]. In addition to its effects on hematopoiesis, GM-CSF can enhance the functional responsiveness and extend the life of mature polymorphonuclear leukocytes (PMN) [2 3 4 ]. PMN are committed to apoptosis, but their progression through the cell death program can be delayed by GM-CSF [3 , 5 , 6 ]. The unnecessary prolongation of the life of granulocytes and augmentation of their bactericidal ability may produce toxic substances such as leukotrienes and superoxide [6 , 7 ]. Activation of neutrophils (PMN) plays a key role in systemic inflammation such as that associated with sepsis and ischemia-reperfusion injury. In fact, the administration of GM-CSF causes side-effects in the form of systemic responses such as shock, hypoxia, liver dysfunction, and respiratory distress [8 , 9 ]. The regulation of cellular apoptosis and the release of toxic substances have been posited as key mechanisms in the inhibition of inflammatory disease and tissue damage [10 11 12 ]. As GM-CSF can make PMN more responsive to secondary stimuli (priming effect) and delay their apoptosis [3 , 7 ] and as PMN play a critical role in inflammation, it is important to identify and examine the mechanism by which GM-CSF delivers functional modulating and/or antiapoptotic signals to PMN.

Phosphoinositide 3-kinases (PI3Ks) constitute a family of lipid kinases that are thought to regulate an array of fundamental cellular responses, including cellular migration, superoxide production, priming effect, and protection from apoptosis in myeloid cells [13 14 15 ]. PMN express all four known PI3K isoforms (PI3K{alpha}, ß, {gamma}, and {delta}). The {alpha}, ß, and {delta} isoforms are composed of a dimer containing a p85 regulatory subunit and a p110 catalytic subunit (type Ia PI3Ks). PI3K{gamma} appears to be composed of a p110 catalytic subunit and a p101 regulatory subunit (type Ib PI3K) [16 ] and in knockout mouse studies, has been proven to be linked to heterotrimeric guanosine 5'-triphosphate (GTP)-binding protein-coupled receptor signaling for cellular migration and superoxide production [17 18 19 20 ]. Specific seven-transmembrane domain receptor agonists, such as C5a, formyl-Met-Leu-Phe (fMLP), and interleukin-8, trigger the formation of phosphatidylinositol 3,4,5-triphosphate. In addition, some pharmacological studies have indicated that GM-CSF also activates PI3K in human neutrophils and that this process is mediated by tyrosine kinases, linked partly to the priming of PMN functions and delay of PMN apoptosis [21 22 23 24 25 26 ]. PI3Ks are known to be activated by a number of growth factor receptor systems and to play essential roles in proliferative and nonproliferative cellular functions. However, it is not clear at present which PI3K isoform enzyme(s) relay signals for these effects induced by GM-CSF.

To clarify the physiological role of the PI3K isoform in PMN activation in the presence of GM-CSF, we used p85{alpha} gene-disrupted mice and their PMN [27 , 28 ] to examine the effects of GM-CSF on PMN functions and survival.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Pik3r1 gene-disrupted mice
A DNA fragment containing the first exon of Pik3r1 was cloned from the D3 genomic library using a human cDNA fragment flanking the antithymoctye globulin translation initiation codon as a probe. Pik3r1-deficient mice were kindly provided by Shigeo Koyasu (Keio University, Japan) with the permission of Takashi Kadowaki (Tokyo University, Japan) [27 , 28 ]. Homologous recombination resulted in the generation of chimeric mice as described elsewhere [29 , 30 ]. Pik3r1-deficient and control wild-type mice were generated by mating heterozygous mice of a similar genetic background (C57BL/6). As disruption of the entire p85{alpha} gene could lead to a lethal phenotype, the first exon of the gene was disrupted, resulting in an abrogated p85{alpha} but intact p55{alpha} and p50{alpha} (p85{alpha}-/-) [27 , 28 ].

Purification of mouse PMN
To obtain enriched populations of PMN, the peritoneal cavity was washed with heparinized phosphate-buffered saline (PBS) 20 h after a peritoneal injection of 2% thioglycollate (2 ml). The PMN population was >90% pure, as assessed by light microscopy of May-Grunwald-Giemsa (Merck Ltd., Darmstadt, Germany)-stained cytospun preparations. The PMN were resuspended in Hanks’ balanced saline solution (HBSS) buffered with 10 mM HEPES, pH 7.35 (Ca2+- and Mg2+-free).

Drugs and analytical reagents
Dextran T500 was obtained from Pharmacia (Uppsala, Sweden). Endotoxin-free Histopaque, fMLP, cytochrome C (type VI), dimethyl sulfoxide (DMSO), N-ethylmaleimide, wortmannin (a PI3K inhibitor), superoxide dismutase (SOD), and mouse tumor necrosis factor {alpha} (TNF-{alpha}) were purchased from Sigma Chemical Co. (St. Louis, MO), and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002; a specific PI3K inhibitor) was from Calbiochem (La Jolla, CA). fMLP and PI3K inhibitors were stocked in DMSO and further diluted with the appropriate medium. The final DMSO concentration did not exceed 0.1% by volume.

Measurement of superoxide anion (O2-) production
Superoxide production in mouse PMN (5x106 cells/ml) was determined at 37°C, as a change in absorbance at 550 nm from the baseline using a Hitachi spectrophotometer U2000 [31 ]. The reaction lasted for 2 min with fMLP (1 µM) in a standard assay mixture with 1.6 mM Ca2+ and 1.0 mM Mg2+. The reaction was stopped by adding 0.5 mM N-ethylmalemide. Superoxide generation was calculated by subtracting the absorbance change in the presence of SOD (1 mM) from that in its absence and then dividing the value for the molar extinction coefficient. In kinetic studies, changes in the absorbance of light at 550 nm were continuously assayed using a cuvette holder maintained at a constant temperature by a thermostat. Recombinant mouse GM-CSF was supplied by Kirin Brewery (Tokyo, Japan). In several experiments, PMN were incubated with 100 ng/ml TNF-{alpha} or 10 ng/ml (45 pM) GM-CSF for 45 min prior to fMLP stimulation.

Cell motility (chemotaxis)
PMN motility was measured using the agarose method [31 ]. Briefly, 5 ml 1.2% agarose dissolved in HBSS containing Ca2+ and Mg2+ and 10% fetal calf serum was placed in 60 x 15-mm Petri dishes. Cell suspension (10 µl) containing 5 x 105 cells was placed in the center well (3-mm diameter) of the plate, and equal volumes of the chemoattractant (2x10-7 M fMLP) and HBSS were placed in the outer and inner wells, respectively. The outer and inner wells were located 7 mm from the center well. After incubation at 37°C in 5% CO2 for 2 h, the plates were fixed with ethanol and formalin, and the cells were stained with Wright’s stain (Sigma Chemical Co.). Cell motility was defined as the linear distance that the cells moved from the center well in the direction of that containing the chemoattractant (chemotaxis). The amount of migration was compared with that of controls. All results represent averages of duplicate measurements.

Cell culture and assessment of apoptosis
A mouse agonistic anti-Fas monoclonal antibody (mAb), apoptosis-inducing RK-8, was purchased from MBL (Nagoya, Japan). The PMN (1x106/ml) were incubated in Ca2+- and Mg2+-free HBSS buffered with 10 mM HEPES, pH 7.35, and containing 2.5% fetal bovine serum, settled with inclination to prevent clotting under a humidified 5% CO2 atmosphere for 8 h. Incubation proceeded in the absence or presence of anti-Fas Ab (RK-8; 500 ng/ml). The percentage of apoptotic cells was analyzed by flow cytometry (FACScan; Becton Dickinson, San Jose, CA) using propidium iodide (PI), and 1 x 104 cells were counted [32 , 33 ]. The PI fluorescence of individual nuclei with an acquisition of FL3 (DNA content) was plotted, and the data registered on a logarithmic scale correlated well with the morphological determination (characteristic chromatin condensation and formation of apoptotic bodies).

DNA fragmentation
PMN (2x106) were lysed by incubation for 15 min in 400 µl of a cold mixture of 10 mM Tris-HCl, pH 7.4, 0.2 mM EDTA, and 0.2% Triton X-100. The lysate was separated by centrifugation, the supernatant was extracted with chloroform/isoamyl alcohol/phenol, and the aqueous phase was collected. The DNA was precipitated with 50% 2-propranol and 0.5 M sodium acetate and placed at -80°C overnight. Following digestion with 50 µg/ml RNase A (Boehringer Mannheim, Mannheim, Germany) for 1 h at 37°C, the samples were resolved by electrophoresis through a 1.2% agarose gel and stained with 0.5 µg/ml ethidium bromide [33 ].

Immunoprecipitations and immunoblotting
Anti-p85 polyclonal Ab against a full-length p85-glutathione-S-transferase fusion protein containing the N-terminal SH2 domain of p85{alpha} and anti-p110{alpha} Ab against the carboxy-terminal region was purchased from Upstate Biotechnology (Lake Placid, NY). Phosphorylated Akt was identified with a polyclonal Ab directed against phosphorylated Ser473 (New England Biolabs, Cambridge, MA). Immunoblotting was performed as described [25 ]. Briefly, PMN (2x107 cells/ml) were incubated with GM-CSF (10 ng/ml) for 3 min, and then cells were pelleted and resuspended in lysis buffer containing Tris-HCl, NaCl, Triton X-100, Nonidet P-40, EDTA, EGTA, Na2VO4, NaF, leupeptin, and phenylmethylsulfonyl fluoride. Protein samples were resolved by electrophoresis and transferred to nitrocellulose membranes, which were then incubated overnight in primary Ab (1:150 dilution) in 5% bovine serum albumin/PBS. Ab bound to the membrane was detected with 125I-labeled protein A. Blots were developed on Fuji X Omat films (Tokyo, Japan) overnight at -70°C.

Statistical analysis
Data are presented as means ± SE. Data were analyzed by Student’s t-test or one-way ANOVA among more than three groups. A P value of <0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
PI3K regulatory subunit isoforms in mouse PMN
We first determined the expression levels of PI3K regulatory subunit isoforms in mouse PMN. Lysates were immunoprecipitated with the p85 Ab, which can recognize the p85{alpha} as well as the p50{alpha} subunit. p85{alpha} and p50{alpha} were precipitated in wild-type and hetero mice. In p85{alpha}-/- mice, however, p50{alpha} was detected only in the major PI3K regulatory subunit (Fig. 1 ), which can also bind to the p110 catalytic subunit and act as a regulatory unit for p110 [28 ]. Thus, despite the complete elimination of full-length p85{alpha}, little PI3K activity could be detected in several cells (including PMN) in the knockout mice (p85{alpha}-/- mice) [27 , 28 ].



View larger version (48K):
[in this window]
[in a new window]
  		Figure 1. Expression patterns of subunits of PI3K in PMN from p85{alpha}-/-, hetero, and wild-type (WT) mice. Purified neutrophils were lysed and immunoprecipitated with the p85 Ab (that cross-reacts with p50{alpha}). In addition, the anti-p110{alpha} Ab cross-reacted with the conjugated p85{alpha} subunit of PI3K but not with p50{alpha} in PMN from WT mice (C).

 
The role of PI3K in O2- production in mouse PMN
We examined the role of PI3K in O2- production in peritoneal mouse PMN elicited by thioglycollate from p85{alpha}-/- and wild-type mice. The time-course study of peritoneal PMN diluted in medium containing 100 nM wortmannin (a PI3K inhibitor) for 30 min showed a dramatic inhibition of O2- production (Fig. 2 ). PMN were finally stimulated by a chemotactic factor (1 µM fMLP) that interacts with GTP-binding protein-coupled receptors [17 18 19 20 ]. Wortmannin also strongly inhibited the GM-CSF-induced augmentation of O2- production in PMN. Similar inhibitions of O2- production were observed in the presence of 10 µM LY294002 (data not shown). The amounts of O2- produced in the PMN of p85{alpha}-/- and wild-type mice stimulated with fMLP did not differ under control conditions (Fig. 3A ). Prior exposure to TNF and GM-CSF can accelerate O2- production stimulated with fMLP (priming effect; P<0.002 by ANOVA). PMN were incubated with 100 ng/ml TNF-{alpha} or 10 ng/ml (45 pM) GM-CSF for 45 min prior to fMLP stimulation. As shown in Figure 3B , the response of PMN from p85{alpha}-/- mice to fMLP was significantly lower than that of PMN from the wild-type mice preincubated with GM-CSF (10 ng/ml: 45 pM for 45 min; P<0.01 by ANOVA; n=3). The enhancement of O2- production by GM-CSF in response to fMLP in p85{alpha}-/- mice was impaired but not completely eliminated (P<0.05 by ANOVA, n=3). Meanwhile, preincubation with TNF (100 ng/ml for 45 min) did not result in any observable difference between the two types of mice.



View larger version (17K):
[in this window]
[in a new window]
  		Figure 2. Effects of wortmannin on superoxide production in mouse PMN (5x106 cells/ml) stimulated with 1 µM fMLP. PMN were preincubated with 100 nM wortmannin for 30 min at 37°C before stimulation with fMLP (solid marks). Changes in absorbance at 550 nm were monitored. Representative results are shown. The experiment was performed three times with similar results. Cells were incubated with 10 ng/ml (45 pM) GM-CSF for 45 min prior to fMLP stimulation (open squares).

 


View larger version (22K):
[in this window]
[in a new window]
  		Figure 3. (A) Time course of O2- production in PMN (5x106 cells/ml) from p85{alpha}-/- and wild-type (WT) mice stimulated with 1 µM fMLP. Representative changes in absorbance at 550 nm from three separate experiments are shown. Cells were incubated with 100 ng/ml TNF-{alpha} or 10 ng/ml (45 pM) GM-CSF for 45 min prior to fMLP stimulation. There was a significant difference in response between p85{alpha}-/- and WT mice (**, P<0.01). (B) Comparison of total amount of O2- production in PMN from p85{alpha}-/- and WT mice determined with a cytochrome C reduction assay. Cells were incubated with 100 ng/ml TNF-{alpha} or 10 ng/ml (45 pM) GM-CSF for 45 min prior to fMLP stimulation. Reaction lasted for 2 min. Data represent means ± SE of three experiments, each conducted in duplicate. There was a significant difference in response from that without cytokines (*, P<0.05; **P<0.01).

 
PMN motility
In addition, we examined PMN chemotaxis in vitro in response to fMLP (2x10-7 M) in agarose. PMN purified from p85{alpha}-/- mice did not differ from that of wild-type mice cells in terms of fMLP-induced chemotactic activities. Preincubation of control PMN with wortmannin (100 nM) or LY294002 (10 µM) for 30 min reduced cell migration of both types of PMN (Fig. 4 ) in a similar manner.



View larger version (50K):
[in this window]
[in a new window]
  		Figure 4. Chemotaxis of mouse PMN under agarose. PMN motility is expressed as means ± SE on a microscopic scale; the actual distance at the front is the number shown multiplied by 0.375 mm. Chemotaxis (solid bars) is defined as the distance cells moved in response to 2 x 10-7 M fMLP in three determinations; spontaneous migration (open bars) is also shown. PMN from WT mice were preincubated with the PI3K inhibitor wortmannin (100 nM) or LY294002 (10 µM) for 30 min. The response differs significantly from that without inhibitors (**, P<0.01).

 
Effect of PI3K on GM-CSF delay of PMN apoptosis and activation of Akt
To determine whether the activation of the PI3K pathway is critical for the GM-CSF-induced delay of PMN apoptosis (survival), we studied the effect of GM-CSF on the anti-Fas mAb-induced PMN apoptosis of p85{alpha}-/- mice. The percentages of apoptotic cells were almost the same for p85{alpha}-/- and wild-type mice without GM-CSF (64±6–68±3%). Figure 5A and 5B , shows that apoptosis was not completely inhibited by GM-CSF in PMN purified from p85{alpha}-/- mice. Similar effects of GM-CSF were observed on spontaneous apoptosis of PMN (without anti-Fas Ab; data not shown). Cellular apoptosis was further confirmed by electrophoresis (Fig. 6 ). Agarose gel electrophoresis of DNA from PMN showed characteristic ladder-like apoptotic patterns (DNA degradation). Ladder formation in DNA extracts was augmented by anti-Fas mAb and inhibited by GM-CSF (Fig. 6) in PMN from wild-type mice (p85{alpha}+/+). PMN apoptosis was not delayed by GM-CSF treatment of PMN from p85{alpha}-/- mice. Preincubating PMN with wortmannin (100 nM) or LY294002 (10 µM) markedly reversed the antiapoptotic effect of GM-CSF as described previously (ref. [25 ]; data not shown). One mechanism of GM-CSF that prevents apoptosis is thought to be the activation of the protein kinase B (PKB)/Akt pathway [25 , 34 ]. We examined the role of this pathway in GM-CSF-induced apoptosis delay. As shown in Figure 7 , GM-CSF caused phosphorylation of Akt in PMN from wild-type mice (p85{alpha}+/+), but this phenomenon was not clearly observed in PMN from p85{alpha}-/- mice.



View larger version (20K):
[in this window]
[in a new window]
  		Figure 5. Loss of DNA in PMN undergoing apoptosis as measured by flow cytometry of PI-stained PMN (A). Wild-type (WT) or p85{alpha}-/- knockout mouse PMN were incubated with anti-Fas Ab (RK-8; 500 ng/ml). After 8 h incubation with/without 10 ng/ml GM-CSF, apoptotic cells as a percentage of the total number of PMN were determined. Results are representative data of three independent experiments. Comparison of percentages of apoptotic cells in PMN from p85{alpha}-/- and WT mice (B) from three independent experiments. The response significantly differs from that of control (**, P<0.01).

 


View larger version (58K):
[in this window]
[in a new window]
  		Figure 6. Agarose gel electrophoresis of DNA extracted from p85{alpha}-/- or wild-type (p85{alpha}+/+) mouse PMN after culture for 8 h under various conditions. M, Molecular weight markers. Cells were incubated with/without 10 ng/ml GM-CSF (GM) and anti-Fas Ab (RK-8; 500 nM).

 


View larger version (39K):
[in this window]
[in a new window]
  		Figure 7. Effect of GM-CSF on phosphorylation of Akt in PMN. PMN were incubated with 10 ng/ml GM-CSF, and cell aliquots were obtained after 45 min incubation at 37°C. Phosphorylation of Akt was determined by immunoblotting. The representative data are shown.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
GM-CSF is a cytokine that plays a key role in regulating the biological activities of PMN [2 3 4 , 8 ], but the exact signaling pathways involved in mediating these effects have not been fully identified or understood. One of the effector systems that GM-CSF is known to activate consists of PI3-kinase [21 22 23 24 25 26 ], which is recruited and activated in several functions of PMN. Previous observations [21 22 23 24 ] showed that PI3K and its p85 regulatory subunit in particular is tyrosine-phosphorylated after the treatment of PMN with GM-CSF and that this phosphorylation is an essential step in activating PI3K{alpha} (Ia-type PI3K). It is possible that GM-CSF augments O2- production and also increases the life span of PMN through PI3K, but the isoform or subunit involved has not been clearly identified [25 , 26 ]. Although its participation is beyond doubt, there was no direct evidence that GM-CSF relays signals via PI3K{alpha} activation during functional augmentation or delaying apoptosis. Therefore, we studied the functions of PMN and cellular survival in p85{alpha} gene-disrupted mice to clarify the role of PI3K{alpha} activation.

In control experiments (without cytokines), the quantity of O2- produced and the extent of chemotactic migration (chemotaxis) as a result of stimulation with fMLP in the PMN of p85{alpha}-/- and wild-type mice showed no significant differences. PMN purified from thioglycollate-treated p85{alpha}-/- mice did not differ from that of wild-type cells in terms of fMLP-induced cellular activation. The chemotaxis and O2- production of PMN from PI3K{gamma}-deficient mice were impaired in response to fMLP [17 18 19 ], and preincubation of PMN with wortmannin or LY294002 (nonspecific PI3K inhibitors) for 30 min also diminished cellular functions. These results indicate that only PI3K{gamma} plays an essential role in chemoattractant-induced PMN activation. These findings also indicate that PI3K{gamma} activity continues in PMN from p85{alpha}-/- mice.

The enhancement of O2- production by GM-CSF in response to fMLP in p85{alpha}-/- mice was poor but not completely eliminated. The remaining PI3K{alpha} activity with the p55{alpha} and p50{alpha} isoforms may have little effect, or it is comprehensible that PI3K{alpha} may have an important but not an essential role in the priming effect of GM-CSF. The activation of mitogen-activated protein kinase (MAPK) subtypes, including extracellular signal-regulated kinases (ERKs; p38 MAPK, ERK1, and ERK2), may be another process that enhances neutrophil function. PMN from p85{alpha}-/- mice and wild-type mice preincubated with TNF (100 ng/ml for 45 min) had a similar priming effect on O2- production. Previous studies revealed that GM-CSF and TNF activate different pathways, which are related to the activation of MAPK subtype cascades of ERK1/ERK2 and p38 MAPK, respectively [35 36 37 ]. Our findings also suggested distinct pathways of PMN activation for these cytokines. Thus, the MAPK subtype cascades may participate in TNF and GM-CSF-mediated priming effects, and this can be interpreted as meaning that the PI3K{alpha}-dependent pathway is mainly involved in the GM-CSF-mediated priming effect.

Previous studies found significant Akt phosphorylation [25 ] and reversal of the GM-CSF-dependent delay of PMN apoptosis as a result of inhibition of PI3K with wortmannin or LY294002 [25 , 26 ]. Our results showed that Akt was not phosphorylated in PMN purified from p85{alpha}-/- mice after incubation with GM-CSF. PMN from PI3K{gamma} knockout mice, however, can activate PKB and phosphorylate Akt in response to GM-CSF but not to fMLP [17 ]. These findings and our results indicate that the PI3K{alpha}/Akt pathway plays a role in initiation of the GM-CSF-stimulated delay of PMN apoptosis. Several investigators have reported that Janus kinase/signal transducer and activator of transcription and MAPKs also play key roles in regulating neutrophil apoptosis [26 , 37 ] and others, that PI3K is an alternative element in the signal transduction pathway leading to ERK activation [38 , 39 ]. Further studies are obviously required to clarify the involvement of ERKs and the precise linkage between ERKs and PI3Ks in GM-CSF-regulating PMN apoptosis.

We identified two important differences in GM-CSF-modulated PMN functions between p85{alpha}-/- and wild-type mice. In the p85{alpha}-/- mice, O2- production of PMN was enhanced by GM-CSF stimulated with fMLP but to a significantly lesser extent than in wild-type mice. In addition, the GM-CSF-dependent delay in apoptosis was considerably less evident in PMN from p85{alpha}-/- mice, and GM-CSF failed to activate the PI3K/Akt pathway as determined by Akt phosphorylation. As our targeting strategy left the expression of the p55{alpha} and p50{alpha} isoforms intact [27 , 28 ], the mutant continued to express a small amount of PI3K{alpha} activity [27 ]. Therefore, it is possible that the effects of GM-CSF on PMN functions or cellular survival in the knockout mice were not completely eliminated.

Our study presents genetic evidence for the critical role of PI3K p85{alpha} gene products in the functioning of GM-CSF-modulated PMN and Akt-dependent prevention of cellular apoptosis. The adapter isoforms encoded by the p85{alpha} gene appear to be critical for PI3K catalytic function, as p85{alpha}-deficient cells greatly reduced p110{alpha} expression and kinase activity [27 ]. To summarize, our results demonstrated that PI3K{alpha} plays a key role in GM-CSF-modulated functions and in the delayed apoptosis of mature, peripheral PMN. The blockade of the PI3K isoform may thus exert an anti-inflammatory effect by promoting cellular apoptosis and sedation of functional priming of PMN. Further studies will be needed to determine whether this pharmacological mechanism is also effective in vivo.


   ACKNOWLEDGEMENTS
 
This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports and Science (12670738) and from the Ministry of Health and Welfare of Japan. We especially thank S. Koyasu (Department of Microbiology and Immunology, Keio University) and T. Kadowaki (Department of Metabolic Diseases, Tokyo University) for providing the p85{alpha}-/- mice.

Received April 10, 2002; revised August 12, 2002; accepted August 21, 2002.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Gasson, J. C., Weisbart, R. H., Kaufman, S. E., Clark, S. C., Hewick, R. M., Wong, G. G. (1984) Purified human granulocyte-macrophage colony-stimulating factor: direct effects on neutrophils Science 226,1339-1342[Abstract/Free Full Text]
  2. Weisbart, R. H., Golde, D. W., Clark, S. C., Wong, G. G., Gasson, J. C. (1985) Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator Nature 314,361-363[Medline]
  3. Lopez, A. F., Williamson, D. J., Gamble, J. R., Begley, C. G., Harlan, J. M., Klebanoff, S. J., Waltersdorph, A., Wong, G., Clark, S. C., Vadas, M. A. (1986) Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival J. Clin. Investig. 78,1220-1228
  4. Mege, J. L., Gomez-Cambronero, J., Molski, T. F. P., Becker, E. L., Sha’afi, R. I. (1989) Effect of granulocyte macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils: role of protein kinase and G-proteins J. Leukoc. Biol. 46,161-168[Abstract]
  5. Wei, S., Liu, J. H., Epling-Burnette, P. K., Gamero, A. M., Ussery, D., Pearson, E. W., Elkabani, M. E., Diaz, J. I., Djeu, J. Y. (1996) Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor J. Immunol. 157,5155-5162[Abstract]
  6. Malech, H. L., Gallin, J. I. (1987) Neutrophils in human diseases N. Engl. J. Med. 317,687-694[Medline]
  7. Hu, B., Yasui, K. (1997) Effects of colony-stimulating factors (CSFs) on neutrophil apoptosis: possible roles at inflammation site Int. J. Hematol. 66,179-188[Medline]
  8. Verhoef, G., Boogaerts, M. (1991) Treatment with granulocyte-macrophage colony-stimulating factor and the adult respiratory distress syndrome Am. J. Hematol. 36,285-287[Medline]
  9. Tiegs, G., Barsig, J., Matiba, B., Uhlig, S., Wendel, A. (1994) Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice J. Clin. Investig. 93,2616-2622
  10. Lee, A., Whyte, M. K., Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators J. Leukoc. Biol. 54,283-288[Abstract]
  11. Liles, W. C., Klebanoff, S. J. (1995) Regulation of apoptosis in neutrophils-Fas track to death? J. Immunol. 155,3289-3291[Medline]
  12. Savill, J. (1997) Apoptosis in resolution of inflammation J. Leukoc. Biol. 61,375-380[Abstract]
  13. Traynor-Kaplan, A. E., Thompson, B. L., Harris, A. L., Taylor, P., Omann, G. M., Sklar, L. A. (1989) Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol triphosphate during activation of human neutrophils J. Biol. Chem. 264,15668-15673[Abstract/Free Full Text]
  14. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., Ui, M. (1994) Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3 kinase J. Biol. Chem. 269,3563-3567[Abstract/Free Full Text]
  15. Vlahos, C. J., Matter, W. F., Brown, R. F., Traynor-Kaplan, A. E., Heyworth, P. G., Prossnitz, E. R., Ye, R. D., Marder, P., Schelm, J. A., Rothfuss, K. J., Serlin, B. S., Simpson, P. J. (1995) Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase J. Immunol. 154,2413-2422[Abstract]
  16. Toker, A., Cantley, L. C. (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase Nature 387,673-676[Medline]
  17. Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I., Joza, N., Mak, T. W., Ohashi, P. S., Suzuki, A., Penninger, J. M. (2000) Function of PI3K{gamma} in thymocyte development, T cell activation, and neutrophil migration Science 287,1040-1046[Abstract/Free Full Text]
  18. Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A. V., Wu, D. (2000) Roles of PLC-ß2 and -ß3 and PI3K{gamma} in chemoattractant-mediated signal transduction Science 287,1046-1049[Abstract/Free Full Text]
  19. Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., Wymann, M. P. (2000) Central role for G protein-coupled phosphoinositide 3-kinase {gamma} in inflammation Science 287,1049-1053[Abstract/Free Full Text]
  20. Naccache, P. H., Levasseur, S., Lachance, G., Chakravarti, S., Bourgoin, S. G., McColl, S. R. (2000) Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase {gamma} J. Biol. Chem. 275,23636-23641[Abstract/Free Full Text]
  21. Al-Shami, A., Bourgoin, S. G., Naccache, P. H. (1997) Granulocyte-macrophage colony-stimulating factor activated signaling pathways in human neutrophils. I. Tyrosine phosphorylation-dependent stimulation of phophatidylinositol 3-kinase and inhibition by phorbol esters Blood 89,1035-1044[Abstract/Free Full Text]
  22. Coffer, P. J., Geijsen, N., M’Rabet, L., Schweizer, R. C., Maikoe, T., Raaijmakers, J. A. M., Lammers, J. J., Koenderman, L. (1998) Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function Biochem. J. 329,121-130
  23. Kodama, T., Hazeki, K., Hazeki, O., Okada, T., Ui, M. (1999) Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production Biochem. J. 337,201-209
  24. Al-Shami, A., Naccache, P. H. (1999) Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils J. Biol. Chem. 274,5333-5338[Abstract/Free Full Text]
  25. Klein, J. B., Rane, M. J., Scherzer, J. A., Coxon, P. Y., Kettritz, R., Mathiesen, J. M., Buridi, A., McLeish, K. R. (2000) Granulocyte-macrophage colony-stimulating factor delays neutrophil aonstitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways J. Immunol. 164,4286-4291[Abstract/Free Full Text]
  26. Epling-Burnette, P. K., Zhong, B., Bai, F., Jiang, K., Bailey, R. D., Garcia, R., Jove, R., Djeu, J. Y., Loughran, T. P., Jr, Wei, S. (2001) Cooperative regulation of Mcl-1 by Janus kinase/STAT and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils J. Immunol. 166,7486-7495[Abstract/Free Full Text]
  27. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., Koyasu, S. (1999) Xid-like immunodeficiency in mice with disruption of the p85{alpha} subunit of phosphoinositide 3-kinase Science 283,390-392[Abstract/Free Full Text]
  28. Terauchi, Y., Tsuji, Y., Satoh, S., Minoura, H., Murakami, K., Okuno, A., Inukai, K., Asano, T., Kaburagi, Y., Ueki, K., Nakajima, H., Hanafusa, T., Matsuzawa, Y., Sekihara, H., Yin, Y., Barrett, J. C., Oda, H., Ishikawa, T., Akanuma, Y., Komuro, I., Suzuki, M., Yamamura, K., Kodama, T., Suzuki, H., Koyasu, S., Aizawa, S., Tobe, K., Fukui, Y., Yazaki, Y., Kadowaki, T. (1999) Increased insulin sensitivity and hypoglycaemia in mice lacking the p85{alpha} subunit of phosphoinositide 3-kinase Nature Genet 21,230-235[Medline]
  29. Yagi, T., Aizawa, S., Tokunaga, T., Shigetani, Y., Takeda, N., Ikawa, Y. (1993) A role for Fyn tyrosine kinase in the sucking behaviour of neonatal mice Nature 366,742-745[Medline]
  30. Yamauchi, T., Tobe, K., Tamemoto, H., Ueki, K., Kaburagi, Y., Yamamoto-Honda, R., Takahashi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., Sonenberg, N., Yazaki, Y., Kadowaki, T. (1996) Insulin signalling and insulin action in the muscles and livers of insulin-resistant, insulin receptor substrate-1 deficient mice Mol. Cell. Biol. 16,3074-3084[Abstract]
  31. Yasui, K., Yamazaki, M., Miyabayashi, M., Tsuno, T., Komiyama, A. (1994) Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor: distinct from the pathway for superoxide anion production J. Immunol. 152,5922-5929[Abstract]
  32. Weinmann, P., Gaehtgens, P., Walzog, B. (1999) Bcl-X1- and Bax-{alpha}-mediated regulation of apoptosis of human neutrophils via caspase-3 Blood 93,3106-3115[Abstract/Free Full Text]
  33. Yasui, K., Hu, B., Nakazawa, T., Agematsu, K., Komiyama, A. (1997) Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition J. Clin. Investig. 100,1677-1684[Medline]
  34. Zundel, W., Giaccia, A. (1998) Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress Genes Dev 12,1941-1946[Abstract/Free Full Text]
  35. McLeish, K. R., Knall, C., Ward, R. A., Gerwins, P., Coxon, P. Y., Klein, J. B., Johnson, G. L. (1998) Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-{alpha} and GM-CSF J. Leukoc. Biol. 64,537-545[Abstract]
  36. Suzuki, K., Hino, M., Hato, F., Tatsumi, N., Kitagawa, S. (1999) Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-{alpha} Blood 93,341-349[Abstract/Free Full Text]
  37. Zhang, L., Himi, T., Morita, I., Murota, S. (2001) Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity Cell Death Differ 8,528-536[Medline]
  38. Hawes, B. E., Luttrell, L. M., Van Biesen, T., Lefkowitz, R. J. (1996) Phosphatidylinositol 3-kinase is an early intermediate in the Gß{gamma}-mediated mitogen-activated protein kinase signaling pathway J. Biol. Chem. 271,12133-12136[Abstract/Free Full Text]
  39. Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., Henson, P. M. (1998) p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils J. Biol. Chem. 273,8389-8397[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Hartl, S. Krauss-Etschmann, B. Koller, P. L. Hordijk, T. W. Kuijpers, F. Hoffmann, A. Hector, E. Eber, V. Marcos, I. Bittmann, et al.
Infiltrated Neutrophils Acquire Novel Chemokine Receptor Expression and Chemokine Responsiveness in Chronic Inflammatory Lung Diseases
J. Immunol., December 1, 2008; 181(11): 8053 - 8067.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Rosas, P. F. Dijkers, C. L. Lindemans, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer
IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with {beta}-catenin relocalization
J. Leukoc. Biol., July 1, 2006; 80(1): 186 - 195.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Sakai, H. Suzuki, H. Oda, T. Akaike, Y. Azuma, T. Murakami, K. Sugi, T. Ito, H. Ichinose, S. Koyasu, et al.
Phosphoinositide 3-Kinase in Nitric Oxide Synthesis in Macrophage: CRITICAL DIMERIZATION OF INDUCIBLE NITRIC-OXIDE SYNTHASE
J. Biol. Chem., June 30, 2006; 281(26): 17736 - 17742.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
C. F. Fortin, A. Larbi, O. Lesur, N. Douziech, and T. Fulop Jr.
Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions
J. Leukoc. Biol., May 1, 2006; 79(5): 1061 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. D. Kobayashi, J. M. Voyich, A. R. Whitney, and F. R. DeLeo
Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor
J. Leukoc. Biol., December 1, 2005; 78(6): 1408 - 1418.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. E. Kilpatrick, S. Sun, and H. M. Korchak
Selective regulation by {delta}-PKC and PI 3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C633 - C642.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. M. Fuhler, K. A. Cadwallader, G. J. Knol, E. R. Chilvers, A. L. Drayer, and E. Vellenga
Disturbed granulocyte macrophage-colony stimulating factor priming of phosphatidylinositol 3,4,5-trisphosphate accumulation and Rac activation in fMLP-stimulated neutrophils from patients with myelodysplasia
J. Leukoc. Biol., July 1, 2004; 76(1): 254 - 262.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Gomez-Cambronero, J. Horn, C. C. Paul, and M. A. Baumann
Granulocyte-Macrophage Colony-Stimulating Factor Is a Chemoattractant Cytokine for Human Neutrophils: Involvement of the Ribosomal p70 S6 Kinase Signaling Pathway
J. Immunol., December 15, 2003; 171(12): 6846 - 6855.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Momose, H. Kurosu, N. Tsujimoto, K. Kontani, K. Tsujita, H. Nishina, and T. Katada
Dual Phosphorylation of Phosphoinositide 3-Kinase Adaptor Grb2-Associated Binder 2 Is Responsible for Superoxide Formation Synergistically Stimulated by Fc{gamma} and Formyl-Methionyl-Leucyl-Phenylalanine Receptors in Differentiated THP-1 Cells
J. Immunol., October 15, 2003; 171(8): 4227 - 4234.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
T. Andrews and K. E. Sullivan
Infections in Patients with Inherited Defects in Phagocytic Function
Clin. Microbiol. Rev., October 1, 2003; 16(4): 597 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Tateda, Y. Ishii, M. Horikawa, T. Matsumoto, S. Miyairi, J. C. Pechere, T. J. Standiford, M. Ishiguro, and K. Yamaguchi
The Pseudomonas aeruginosa Autoinducer N-3-Oxododecanoyl Homoserine Lactone Accelerates Apoptosis in Macrophages and Neutrophils
Infect. Immun., October 1, 2003; 71(10): 5785 - 5793.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasui, K.
Right arrow Articles by Suzuki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasui, K.
Right arrow Articles by Suzuki, H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS